| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 82 | 2026 | 630 | 4.730 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 9 | 2021 | 112 | 1.650 |
Why?
|
| Rats | 122 | 2021 | 1996 | 1.600 |
Why?
|
| Rats, Inbred BB | 68 | 2021 | 134 | 1.490 |
Why?
|
| Autoimmunity | 12 | 2021 | 249 | 1.320 |
Why?
|
| Genetic Predisposition to Disease | 21 | 2026 | 734 | 1.280 |
Why?
|
| Blood Glucose | 7 | 2026 | 502 | 1.230 |
Why?
|
| Diabetes Mellitus, Experimental | 39 | 2021 | 206 | 1.100 |
Why?
|
| Antibodies, Monoclonal | 42 | 2021 | 875 | 1.060 |
Why?
|
| T-Lymphocytes | 46 | 2012 | 1008 | 0.980 |
Why?
|
| Membrane Glycoproteins | 39 | 2005 | 662 | 0.970 |
Why?
|
| Graft Survival | 22 | 2007 | 299 | 0.900 |
Why?
|
| Hyperglycemia | 2 | 2026 | 109 | 0.890 |
Why?
|
| Skin Transplantation | 24 | 2007 | 154 | 0.880 |
Why?
|
| ADP Ribose Transferases | 24 | 2006 | 62 | 0.870 |
Why?
|
| Islets of Langerhans Transplantation | 21 | 2006 | 179 | 0.830 |
Why?
|
| Autoimmune Diseases | 26 | 2006 | 239 | 0.750 |
Why?
|
| Hyperinsulinism | 2 | 2015 | 26 | 0.750 |
Why?
|
| Animals | 164 | 2021 | 21394 | 0.730 |
Why?
|
| Intensive Care Units | 1 | 2026 | 435 | 0.730 |
Why?
|
| Chromosome Mapping | 8 | 2009 | 296 | 0.710 |
Why?
|
| Hypoglycemia | 2 | 2015 | 64 | 0.710 |
Why?
|
| Rats, Inbred Strains | 32 | 2013 | 150 | 0.650 |
Why?
|
| Poly I-C | 16 | 2013 | 76 | 0.610 |
Why?
|
| CD40 Ligand | 31 | 2006 | 159 | 0.610 |
Why?
|
| Disease Models, Animal | 21 | 2014 | 2307 | 0.550 |
Why?
|
| Transplantation, Heterologous | 8 | 2006 | 241 | 0.530 |
Why?
|
| Diabetes Mellitus | 10 | 2011 | 555 | 0.530 |
Why?
|
| Parvovirus | 7 | 2016 | 25 | 0.510 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2026 | 512 | 0.490 |
Why?
|
| Immune Tolerance | 13 | 2008 | 184 | 0.490 |
Why?
|
| Islets of Langerhans | 21 | 2013 | 286 | 0.480 |
Why?
|
| Parvoviridae Infections | 4 | 2009 | 23 | 0.460 |
Why?
|
| Transplantation Tolerance | 10 | 2009 | 69 | 0.460 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2015 | 12 | 0.450 |
Why?
|
| Anti-Obesity Agents | 1 | 2015 | 16 | 0.440 |
Why?
|
| Blood Transfusion | 14 | 2004 | 167 | 0.440 |
Why?
|
| Histocompatibility Antigens | 20 | 2001 | 107 | 0.430 |
Why?
|
| T-Lymphocyte Subsets | 9 | 2013 | 241 | 0.420 |
Why?
|
| Gastric Bypass | 1 | 2015 | 69 | 0.420 |
Why?
|
| Weight Loss | 2 | 2015 | 275 | 0.390 |
Why?
|
| HLA-DR alpha-Chains | 2 | 2026 | 7 | 0.380 |
Why?
|
| Rats, Inbred Lew | 11 | 2021 | 106 | 0.380 |
Why?
|
| Thymus Gland | 17 | 2009 | 240 | 0.380 |
Why?
|
| Pancreas | 9 | 2003 | 153 | 0.380 |
Why?
|
| Spleen | 31 | 2009 | 476 | 0.370 |
Why?
|
| CD4-Positive T-Lymphocytes | 14 | 2009 | 642 | 0.370 |
Why?
|
| Lymphocyte Activation | 22 | 2009 | 754 | 0.360 |
Why?
|
| Insulin | 9 | 2021 | 696 | 0.360 |
Why?
|
| Major Histocompatibility Complex | 4 | 2009 | 85 | 0.350 |
Why?
|
| CD8-Positive T-Lymphocytes | 17 | 2021 | 677 | 0.350 |
Why?
|
| Female | 72 | 2026 | 34216 | 0.340 |
Why?
|
| Male | 73 | 2026 | 31208 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 36 | 2009 | 3489 | 0.320 |
Why?
|
| Endothelium, Vascular | 4 | 1996 | 177 | 0.320 |
Why?
|
| Mice, Inbred NOD | 16 | 2009 | 526 | 0.310 |
Why?
|
| Nifedipine | 1 | 2010 | 18 | 0.310 |
Why?
|
| Lymphocyte Depletion | 18 | 2004 | 96 | 0.300 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 26 | 2001 | 111 | 0.300 |
Why?
|
| Mice | 63 | 2010 | 11145 | 0.300 |
Why?
|
| Virus Diseases | 3 | 2009 | 117 | 0.290 |
Why?
|
| Graft Rejection | 14 | 2006 | 303 | 0.290 |
Why?
|
| Immunization | 1 | 2009 | 135 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 25 | 2010 | 868 | 0.290 |
Why?
|
| Killer Cells, Natural | 8 | 2004 | 220 | 0.280 |
Why?
|
| Transplantation Immunology | 4 | 2007 | 26 | 0.280 |
Why?
|
| Genotype | 4 | 2021 | 674 | 0.260 |
Why?
|
| Introns | 2 | 2026 | 114 | 0.260 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 34 | 0.250 |
Why?
|
| Obesity | 1 | 2015 | 1276 | 0.250 |
Why?
|
| Insulin-Secreting Cells | 3 | 2021 | 195 | 0.240 |
Why?
|
| Alleles | 6 | 2019 | 455 | 0.240 |
Why?
|
| Complement C4a | 1 | 2026 | 4 | 0.240 |
Why?
|
| Prediabetic State | 4 | 2019 | 54 | 0.240 |
Why?
|
| Celiac Disease | 1 | 2026 | 19 | 0.230 |
Why?
|
| Equipment Failure | 1 | 2026 | 69 | 0.230 |
Why?
|
| Rats, Inbred WF | 21 | 2004 | 56 | 0.230 |
Why?
|
| Transplantation, Homologous | 18 | 2007 | 250 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2019 | 733 | 0.210 |
Why?
|
| Transplantation Chimera | 4 | 2007 | 41 | 0.210 |
Why?
|
| Humans | 43 | 2026 | 65498 | 0.210 |
Why?
|
| Point-of-Care Systems | 1 | 2026 | 137 | 0.210 |
Why?
|
| Immunogenetics | 1 | 2004 | 4 | 0.210 |
Why?
|
| CD3 Complex | 4 | 2021 | 63 | 0.200 |
Why?
|
| Lymphopenia | 7 | 2009 | 35 | 0.200 |
Why?
|
| Lymphocyte Transfusion | 10 | 2003 | 37 | 0.200 |
Why?
|
| Bone Marrow Transplantation | 7 | 2007 | 140 | 0.190 |
Why?
|
| GTP-Binding Proteins | 3 | 2009 | 93 | 0.190 |
Why?
|
| Antigens, CD | 5 | 2021 | 344 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2021 | 281 | 0.190 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2016 | 54 | 0.190 |
Why?
|
| Interferon Type I | 3 | 2016 | 197 | 0.190 |
Why?
|
| Hematopoiesis | 5 | 2007 | 127 | 0.190 |
Why?
|
| Interferon-gamma | 11 | 2009 | 575 | 0.180 |
Why?
|
| Signal Transduction | 10 | 2010 | 3156 | 0.180 |
Why?
|
| Lymphocytes | 7 | 2003 | 209 | 0.180 |
Why?
|
| Isoantigens | 10 | 2007 | 72 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2021 | 179 | 0.180 |
Why?
|
| Mice, Inbred CBA | 12 | 2007 | 80 | 0.180 |
Why?
|
| Gene Expression Regulation | 6 | 2013 | 1632 | 0.180 |
Why?
|
| Genetic Linkage | 4 | 2009 | 97 | 0.170 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2021 | 20 | 0.170 |
Why?
|
| Organometallic Compounds | 2 | 1993 | 71 | 0.170 |
Why?
|
| Indoles | 2 | 1993 | 112 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2026 | 1710 | 0.170 |
Why?
|
| Autoantibodies | 7 | 1996 | 185 | 0.160 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 70 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 5 | 2007 | 222 | 0.160 |
Why?
|
| Cytokines | 6 | 2003 | 956 | 0.150 |
Why?
|
| Cells, Cultured | 14 | 2016 | 2188 | 0.150 |
Why?
|
| HLA-DR3 Antigen | 1 | 2019 | 7 | 0.150 |
Why?
|
| Resistance Training | 1 | 2019 | 22 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2021 | 417 | 0.150 |
Why?
|
| Exercise Therapy | 1 | 2019 | 102 | 0.140 |
Why?
|
| Adult | 5 | 2026 | 17467 | 0.140 |
Why?
|
| Protein Binding | 2 | 2021 | 1632 | 0.130 |
Why?
|
| Mice, SCID | 7 | 2007 | 518 | 0.130 |
Why?
|
| Middle Aged | 6 | 2026 | 18393 | 0.130 |
Why?
|
| Time Factors | 15 | 2019 | 3774 | 0.130 |
Why?
|
| Immunosuppressive Agents | 5 | 2003 | 381 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 2 | 2009 | 177 | 0.130 |
Why?
|
| Genetic Markers | 5 | 2004 | 129 | 0.130 |
Why?
|
| Haplotypes | 2 | 2026 | 135 | 0.130 |
Why?
|
| Clonal Anergy | 2 | 2009 | 22 | 0.130 |
Why?
|
| Aged | 5 | 2026 | 15062 | 0.130 |
Why?
|
| Stress, Physiological | 4 | 2009 | 210 | 0.130 |
Why?
|
| Antigens | 4 | 2010 | 145 | 0.120 |
Why?
|
| Immunity, Innate | 12 | 2016 | 828 | 0.120 |
Why?
|
| CD40 Antigens | 8 | 2006 | 59 | 0.120 |
Why?
|
| Immunization, Passive | 9 | 1994 | 96 | 0.110 |
Why?
|
| Antigens, Differentiation | 4 | 2000 | 144 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 104 | 0.110 |
Why?
|
| Toll-Like Receptors | 3 | 2006 | 434 | 0.110 |
Why?
|
| Disease Susceptibility | 10 | 2014 | 169 | 0.110 |
Why?
|
| Crosses, Genetic | 5 | 2007 | 116 | 0.110 |
Why?
|
| Venules | 3 | 1993 | 8 | 0.110 |
Why?
|
| Adoptive Transfer | 7 | 2006 | 145 | 0.110 |
Why?
|
| Antibodies | 3 | 2006 | 187 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 2004 | 138 | 0.110 |
Why?
|
| Apoptosis | 6 | 2009 | 1098 | 0.110 |
Why?
|
| Immunoconjugates | 3 | 2000 | 95 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 122 | 0.100 |
Why?
|
| Coloring Agents | 2 | 1999 | 51 | 0.100 |
Why?
|
| Receptors, Interleukin-2 | 6 | 2003 | 71 | 0.100 |
Why?
|
| Homozygote | 4 | 2019 | 122 | 0.100 |
Why?
|
| Parvovirinae | 1 | 2014 | 3 | 0.100 |
Why?
|
| Graft vs Host Disease | 4 | 2003 | 113 | 0.100 |
Why?
|
| Exercise | 2 | 2019 | 968 | 0.100 |
Why?
|
| Ubiquitins | 1 | 2014 | 42 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 1994 | 95 | 0.100 |
Why?
|
| Species Specificity | 10 | 2003 | 340 | 0.100 |
Why?
|
| Interleukin-4 | 6 | 2009 | 147 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 5 | 2001 | 31 | 0.100 |
Why?
|
| Liver | 4 | 2006 | 871 | 0.100 |
Why?
|
| Prostaglandins | 1 | 1993 | 18 | 0.100 |
Why?
|
| Anorexia | 2 | 1984 | 4 | 0.100 |
Why?
|
| Leydig Cell Tumor | 2 | 1984 | 3 | 0.100 |
Why?
|
| Disease Resistance | 1 | 2013 | 27 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2007 | 248 | 0.100 |
Why?
|
| Flow Cytometry | 8 | 2006 | 663 | 0.100 |
Why?
|
| Transplantation Conditioning | 5 | 2006 | 101 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 431 | 0.090 |
Why?
|
| Diabetes Complications | 2 | 2011 | 106 | 0.090 |
Why?
|
| Feeding and Eating Disorders | 2 | 1984 | 53 | 0.090 |
Why?
|
| Mice, Knockout | 10 | 2014 | 2162 | 0.090 |
Why?
|
| Intestinal Mucosa | 3 | 2004 | 250 | 0.090 |
Why?
|
| Vaccinia virus | 2 | 2009 | 69 | 0.090 |
Why?
|
| RNA, Messenger | 5 | 2012 | 1577 | 0.090 |
Why?
|
| Immunophenotyping | 7 | 2001 | 194 | 0.090 |
Why?
|
| Comorbidity | 1 | 2015 | 1120 | 0.090 |
Why?
|
| Cultural Competency | 1 | 2011 | 58 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1993 | 202 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2011 | 97 | 0.090 |
Why?
|
| DNA Primers | 3 | 2009 | 301 | 0.090 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2002 | 52 | 0.090 |
Why?
|
| Toll-Like Receptor 3 | 3 | 2007 | 66 | 0.080 |
Why?
|
| Lymphoid Tissue | 4 | 2002 | 54 | 0.080 |
Why?
|
| Models, Animal | 2 | 2009 | 242 | 0.080 |
Why?
|
| Radiation Chimera | 4 | 2006 | 61 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2012 | 142 | 0.080 |
Why?
|
| Haptoglobins | 1 | 2010 | 13 | 0.080 |
Why?
|
| Secretory Vesicles | 1 | 2010 | 24 | 0.080 |
Why?
|
| Community Health Services | 1 | 2011 | 127 | 0.080 |
Why?
|
| Base Sequence | 4 | 2009 | 1331 | 0.080 |
Why?
|
| Bone Marrow | 7 | 2002 | 176 | 0.080 |
Why?
|
| NAD | 3 | 2001 | 54 | 0.080 |
Why?
|
| Adolescent | 2 | 2026 | 6333 | 0.080 |
Why?
|
| Centrosome | 1 | 2010 | 72 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 1990 | 40 | 0.080 |
Why?
|
| Cell Differentiation | 7 | 2004 | 1387 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 1997 | 169 | 0.080 |
Why?
|
| Enterovirus B, Human | 1 | 2009 | 17 | 0.080 |
Why?
|
| Enterovirus Infections | 1 | 2009 | 12 | 0.080 |
Why?
|
| Transcriptome | 1 | 2013 | 399 | 0.080 |
Why?
|
| Veins | 1 | 1990 | 63 | 0.080 |
Why?
|
| Transcription Factor CHOP | 1 | 2009 | 8 | 0.070 |
Why?
|
| Interleukin-2 | 5 | 2009 | 167 | 0.070 |
Why?
|
| Adenosine Diphosphate Ribose | 5 | 2006 | 16 | 0.070 |
Why?
|
| Galactosylceramides | 1 | 2009 | 11 | 0.070 |
Why?
|
| Aging | 6 | 2001 | 774 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 1 | 2009 | 68 | 0.070 |
Why?
|
| Graft Enhancement, Immunologic | 2 | 2006 | 10 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2007 | 625 | 0.070 |
Why?
|
| Biomarkers | 2 | 2011 | 1484 | 0.070 |
Why?
|
| Body Weight | 5 | 1990 | 376 | 0.070 |
Why?
|
| Dendritic Cells | 4 | 2004 | 531 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 152 | 0.070 |
Why?
|
| CD8 Antigens | 7 | 2003 | 53 | 0.070 |
Why?
|
| Antibodies, Blocking | 3 | 2003 | 39 | 0.070 |
Why?
|
| Macrophages | 6 | 2021 | 1038 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2004 | 718 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1172 | 0.070 |
Why?
|
| Mice, Inbred C3H | 6 | 2007 | 173 | 0.070 |
Why?
|
| Lymph Nodes | 9 | 2003 | 237 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2008 | 102 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2007 | 924 | 0.070 |
Why?
|
| Cell Survival | 6 | 2009 | 588 | 0.070 |
Why?
|
| China | 2 | 2019 | 177 | 0.060 |
Why?
|
| Health Promotion | 1 | 2011 | 523 | 0.060 |
Why?
|
| Bone Marrow Cells | 2 | 2004 | 237 | 0.060 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2006 | 24 | 0.060 |
Why?
|
| Combined Modality Therapy | 6 | 2004 | 372 | 0.060 |
Why?
|
| Leukocyte Transfusion | 2 | 2004 | 16 | 0.060 |
Why?
|
| Health | 1 | 2007 | 30 | 0.060 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2006 | 4 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1987 | 112 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 132 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2006 | 506 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 24 | 0.060 |
Why?
|
| Interleukins | 3 | 2010 | 88 | 0.060 |
Why?
|
| Concanavalin A | 5 | 2003 | 40 | 0.060 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2007 | 207 | 0.060 |
Why?
|
| Pancreatitis | 4 | 1999 | 96 | 0.060 |
Why?
|
| Blotting, Western | 6 | 2010 | 611 | 0.060 |
Why?
|
| Arthritis | 1 | 2005 | 52 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2002 | 857 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 542 | 0.050 |
Why?
|
| NAD+ Nucleosidase | 2 | 2001 | 10 | 0.050 |
Why?
|
| Collagen | 1 | 2005 | 135 | 0.050 |
Why?
|
| Risk Factors | 1 | 2015 | 5462 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2006 | 239 | 0.050 |
Why?
|
| Lectins, C-Type | 2 | 2002 | 80 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2005 | 208 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2015 | 5811 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2013 | 376 | 0.050 |
Why?
|
| Rats, Mutant Strains | 2 | 2002 | 10 | 0.050 |
Why?
|
| Lymphocyte Count | 5 | 2004 | 71 | 0.050 |
Why?
|
| Mice, Transgenic | 5 | 2006 | 1290 | 0.050 |
Why?
|
| Microcirculation | 2 | 1996 | 59 | 0.050 |
Why?
|
| Rats, Nude | 6 | 2001 | 25 | 0.050 |
Why?
|
| Estradiol | 1 | 1984 | 260 | 0.050 |
Why?
|
| Thyroiditis | 4 | 1996 | 11 | 0.050 |
Why?
|
| Pancreatic Polypeptide | 1 | 1982 | 10 | 0.050 |
Why?
|
| Pregnancy | 2 | 2009 | 2392 | 0.050 |
Why?
|
| Pancreatic Diseases | 1 | 2002 | 38 | 0.050 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 8 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2003 | 109 | 0.050 |
Why?
|
| Interleukin-12 | 2 | 2009 | 127 | 0.050 |
Why?
|
| Mice, Obese | 1 | 1982 | 80 | 0.050 |
Why?
|
| Tissue Donors | 5 | 2003 | 146 | 0.050 |
Why?
|
| Recombinant Proteins | 5 | 2006 | 708 | 0.050 |
Why?
|
| Diarrhea | 1 | 1982 | 73 | 0.040 |
Why?
|
| GPI-Linked Proteins | 2 | 1999 | 38 | 0.040 |
Why?
|
| Pyrophosphatases | 1 | 2001 | 11 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2001 | 85 | 0.040 |
Why?
|
| Recurrence | 4 | 2006 | 662 | 0.040 |
Why?
|
| Thymectomy | 5 | 2000 | 35 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2001 | 53 | 0.040 |
Why?
|
| Cell Line | 6 | 2009 | 2024 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 1981 | 35 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2019 | 395 | 0.040 |
Why?
|
| Antigens, Surface | 4 | 2009 | 199 | 0.040 |
Why?
|
| Diet | 2 | 2011 | 536 | 0.040 |
Why?
|
| Phenotype | 7 | 2009 | 1233 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2002 | 180 | 0.040 |
Why?
|
| Thyroiditis, Autoimmune | 2 | 1990 | 8 | 0.040 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 982 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 367 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 213 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2000 | 88 | 0.040 |
Why?
|
| Animals, Newborn | 4 | 2004 | 241 | 0.040 |
Why?
|
| CD28 Antigens | 3 | 2006 | 62 | 0.040 |
Why?
|
| Mitochondria | 1 | 2003 | 410 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 3 | 2006 | 58 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2001 | 321 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 353 | 0.040 |
Why?
|
| Age Factors | 5 | 2013 | 1592 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1999 | 6 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1999 | 17 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2019 | 124 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 449 | 0.040 |
Why?
|
| Cattle | 2 | 1997 | 320 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 441 | 0.040 |
Why?
|
| Multigene Family | 1 | 1999 | 106 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2010 | 89 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 1998 | 35 | 0.030 |
Why?
|
| Cricetinae | 3 | 2006 | 363 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2009 | 1039 | 0.030 |
Why?
|
| Heat-Shock Proteins | 2 | 2009 | 71 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2008 | 391 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1225 | 0.030 |
Why?
|
| Proteins | 2 | 2002 | 764 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 4 | 1995 | 104 | 0.030 |
Why?
|
| Molecular Chaperones | 2 | 2009 | 100 | 0.030 |
Why?
|
| Gene Expression | 3 | 2014 | 854 | 0.030 |
Why?
|
| Child | 2 | 2026 | 4623 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 908 | 0.030 |
Why?
|
| Isoantibodies | 2 | 1996 | 35 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 3 | 2003 | 47 | 0.030 |
Why?
|
| Milk Proteins | 1 | 1997 | 45 | 0.030 |
Why?
|
| Caseins | 1 | 1997 | 42 | 0.030 |
Why?
|
| Milk | 1 | 1997 | 47 | 0.030 |
Why?
|
| Organ Culture Techniques | 3 | 2003 | 62 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 1588 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2010 | 233 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2004 | 1557 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 1996 | 64 | 0.030 |
Why?
|
| Interferons | 2 | 1994 | 74 | 0.030 |
Why?
|
| Catalysis | 3 | 2006 | 164 | 0.030 |
Why?
|
| Chimera | 2 | 1997 | 44 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 2002 | 332 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1143 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 211 | 0.030 |
Why?
|
| Terminology as Topic | 3 | 1999 | 144 | 0.030 |
Why?
|
| Young Adult | 1 | 2026 | 4839 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 1996 | 83 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 1999 | 513 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2007 | 350 | 0.030 |
Why?
|
| Silicon Dioxide | 2 | 1999 | 63 | 0.030 |
Why?
|
| Autoantigens | 2 | 2013 | 140 | 0.030 |
Why?
|
| CTLA-4 Antigen | 3 | 2000 | 72 | 0.030 |
Why?
|
| Abatacept | 3 | 2000 | 67 | 0.030 |
Why?
|
| Swine | 1 | 1996 | 397 | 0.030 |
Why?
|
| Administration, Oral | 1 | 1996 | 371 | 0.030 |
Why?
|
| Interferon Inducers | 2 | 2007 | 11 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 1994 | 6 | 0.030 |
Why?
|
| Cell Division | 3 | 2003 | 450 | 0.030 |
Why?
|
| Cytotoxins | 1 | 1994 | 11 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2014 | 67 | 0.030 |
Why?
|
| In Vitro Techniques | 4 | 1999 | 491 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 1996 | 300 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 1568 | 0.030 |
Why?
|
| Sex Factors | 2 | 2009 | 995 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 235 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 2010 | 154 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1996 | 185 | 0.020 |
Why?
|
| Solubility | 3 | 2001 | 192 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1993 | 8 | 0.020 |
Why?
|
| Tolmetin | 1 | 1993 | 10 | 0.020 |
Why?
|
| Ketorolac | 1 | 1993 | 13 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 1993 | 16 | 0.020 |
Why?
|
| Clone Cells | 2 | 2004 | 111 | 0.020 |
Why?
|
| Ibuprofen | 1 | 1993 | 17 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 225 | 0.020 |
Why?
|
| Misoprostol | 1 | 1993 | 9 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2015 | 535 | 0.020 |
Why?
|
| Environment | 2 | 1991 | 125 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 312 | 0.020 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 369 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 1997 | 1979 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 160 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 181 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2013 | 165 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 2 | 2002 | 8 | 0.020 |
Why?
|
| Lod Score | 2 | 2004 | 23 | 0.020 |
Why?
|
| Microsatellite Repeats | 2 | 2004 | 42 | 0.020 |
Why?
|
| Coculture Techniques | 2 | 2003 | 104 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 2003 | 102 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 1991 | 10 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 900 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2004 | 69 | 0.020 |
Why?
|
| DNA, Viral | 2 | 2007 | 232 | 0.020 |
Why?
|
| Models, Biological | 4 | 2008 | 1192 | 0.020 |
Why?
|
| B7-1 Antigen | 2 | 2003 | 74 | 0.020 |
Why?
|
| Virus Physiological Phenomena | 1 | 1991 | 8 | 0.020 |
Why?
|
| Disease Progression | 2 | 2010 | 1224 | 0.020 |
Why?
|
| Azathioprine | 1 | 1991 | 27 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 687 | 0.020 |
Why?
|
| CD4 Antigens | 2 | 2003 | 149 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 37 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1991 | 77 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2010 | 27 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 863 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2001 | 300 | 0.020 |
Why?
|
| Prednisone | 1 | 1991 | 83 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1991 | 110 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 63 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 26 | 0.020 |
Why?
|
| Genes | 1 | 1990 | 90 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2003 | 186 | 0.020 |
Why?
|
| Kinetics | 2 | 2002 | 757 | 0.020 |
Why?
|
| Aziridines | 1 | 1990 | 3 | 0.020 |
Why?
|
| Homeostasis | 2 | 2010 | 380 | 0.020 |
Why?
|
| Fatty Acids, Essential | 1 | 1990 | 8 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 796 | 0.020 |
Why?
|
| HIV-1 | 1 | 1995 | 706 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 139 | 0.020 |
Why?
|
| Carrageenan | 1 | 1990 | 18 | 0.020 |
Why?
|
| Life Style | 1 | 2011 | 323 | 0.020 |
Why?
|
| Poverty | 1 | 2011 | 307 | 0.020 |
Why?
|
| B-Lymphocytes | 2 | 2007 | 563 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1990 | 127 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 28 | 0.020 |
Why?
|
| Columbidae | 1 | 2009 | 15 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 804 | 0.020 |
Why?
|
| Genome | 2 | 2004 | 285 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 274 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2004 | 962 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2009 | 64 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 204 | 0.020 |
Why?
|
| HIV Infections | 1 | 1995 | 957 | 0.020 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2008 | 5 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2008 | 17 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2011 | 415 | 0.020 |
Why?
|
| Ionomycin | 1 | 2008 | 16 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2001 | 35 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 897 | 0.020 |
Why?
|
| Ligands | 2 | 2000 | 414 | 0.020 |
Why?
|
| Health Behavior | 1 | 2011 | 485 | 0.020 |
Why?
|
| Immune System | 1 | 1989 | 132 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 2001 | 27 | 0.020 |
Why?
|
| Castration | 2 | 1984 | 43 | 0.020 |
Why?
|
| CD5 Antigens | 2 | 2001 | 18 | 0.020 |
Why?
|
| Spodoptera | 2 | 1997 | 27 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 700 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 29 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2007 | 203 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 56 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2006 | 31 | 0.020 |
Why?
|
| Telomere | 1 | 2007 | 58 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2006 | 19 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2006 | 22 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 198 | 0.020 |
Why?
|
| Host vs Graft Reaction | 1 | 2006 | 3 | 0.020 |
Why?
|
| Subrenal Capsule Assay | 1 | 2006 | 3 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2006 | 33 | 0.020 |
Why?
|
| Forecasting | 1 | 1987 | 230 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2006 | 9 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2006 | 13 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1999 | 501 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2006 | 29 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2006 | 38 | 0.010 |
Why?
|
| Immunity, Cellular | 2 | 2003 | 170 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2007 | 145 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 2153 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 323 | 0.010 |
Why?
|
| Isoenzymes | 2 | 2001 | 130 | 0.010 |
Why?
|
| Thymidine | 2 | 1996 | 25 | 0.010 |
Why?
|
| Parvoviridae | 1 | 2005 | 5 | 0.010 |
Why?
|
| Metrizamide | 1 | 2004 | 4 | 0.010 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2004 | 8 | 0.010 |
Why?
|
| Vaccinia | 1 | 2005 | 29 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 435 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 672 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2005 | 58 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1984 | 7 | 0.010 |
Why?
|
| Estrone | 1 | 1984 | 13 | 0.010 |
Why?
|
| Parabiosis | 1 | 1984 | 3 | 0.010 |
Why?
|
| Hypothalamus, Middle | 1 | 1984 | 20 | 0.010 |
Why?
|
| Immunocompetence | 1 | 2004 | 21 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1984 | 51 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 105 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 80 | 0.010 |
Why?
|
| Lymphopoiesis | 1 | 2004 | 27 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1984 | 167 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2004 | 2 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 604 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 2 | 1999 | 236 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 185 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2003 | 34 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2003 | 49 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2003 | 16 | 0.010 |
Why?
|
| Testosterone | 1 | 1984 | 128 | 0.010 |
Why?
|
| B7-2 Antigen | 1 | 2003 | 32 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1994 | 50 | 0.010 |
Why?
|
| Myocardium | 1 | 1985 | 302 | 0.010 |
Why?
|
| Lymphocytosis | 1 | 2003 | 4 | 0.010 |
Why?
|
| Cell Count | 1 | 2003 | 128 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 44 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 140 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 218 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2003 | 75 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2002 | 19 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 624 | 0.010 |
Why?
|
| Mitosis | 1 | 1984 | 222 | 0.010 |
Why?
|
| Chromosomes | 1 | 2004 | 139 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 1155 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2003 | 178 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 2002 | 44 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 176 | 0.010 |
Why?
|
| DNA | 2 | 1997 | 852 | 0.010 |
Why?
|
| Reference Values | 2 | 1994 | 328 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2004 | 273 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 2001 | 63 | 0.010 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2001 | 5 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 2001 | 6 | 0.010 |
Why?
|
| Mitogens | 1 | 2001 | 10 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2001 | 14 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 2001 | 14 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 433 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2001 | 15 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2001 | 34 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2001 | 44 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 2001 | 29 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1983 | 142 | 0.010 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2001 | 33 | 0.010 |
Why?
|
| Viral Load | 1 | 2002 | 230 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1984 | 400 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2001 | 33 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1981 | 55 | 0.010 |
Why?
|
| Alloxan | 1 | 1981 | 1 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2001 | 34 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 184 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1981 | 77 | 0.010 |
Why?
|
| Streptozocin | 1 | 1981 | 23 | 0.010 |
Why?
|
| Macaca | 1 | 1981 | 30 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 54 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1981 | 86 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2001 | 27 | 0.010 |
Why?
|
| Adenosine | 1 | 2001 | 78 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 325 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 141 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 426 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2002 | 282 | 0.010 |
Why?
|
| Hormones | 1 | 1981 | 62 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 104 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1981 | 134 | 0.010 |
Why?
|
| Leukocyte Count | 2 | 1994 | 102 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2000 | 42 | 0.010 |
Why?
|
| Pichinde virus | 1 | 2000 | 20 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 1991 | 75 | 0.010 |
Why?
|
| Dogs | 1 | 1981 | 315 | 0.010 |
Why?
|
| Mice, Mutant Strains | 2 | 1991 | 301 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2001 | 284 | 0.010 |
Why?
|
| Povidone | 1 | 1999 | 8 | 0.010 |
Why?
|
| Age of Onset | 1 | 1999 | 174 | 0.010 |
Why?
|
| Thy-1 Antigens | 1 | 1999 | 21 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1999 | 11 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 35 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1999 | 37 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1999 | 84 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1999 | 27 | 0.010 |
Why?
|
| Peyer's Patches | 1 | 1999 | 34 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1999 | 30 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1998 | 28 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1998 | 41 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 293 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1998 | 63 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 1998 | 118 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 1999 | 121 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1998 | 82 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 296 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1997 | 47 | 0.010 |
Why?
|
| Baculoviridae | 1 | 1997 | 24 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 223 | 0.010 |
Why?
|
| Cell Movement | 1 | 1999 | 482 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1997 | 77 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 300 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1996 | 62 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1999 | 413 | 0.010 |
Why?
|
| Rats, Inbred BUF | 2 | 1986 | 10 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1996 | 202 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 118 | 0.010 |
Why?
|
| Neurons | 1 | 2001 | 934 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1994 | 56 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 100 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1994 | 58 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 152 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1994 | 213 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1993 | 52 | 0.010 |
Why?
|
| Incidence | 1 | 1997 | 1431 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1993 | 72 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1993 | 200 | 0.010 |
Why?
|
| Cell Communication | 1 | 1993 | 133 | 0.010 |
Why?
|
| Killer Factors, Yeast | 1 | 1991 | 3 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1991 | 74 | 0.010 |
Why?
|
| Causality | 1 | 1991 | 60 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1990 | 24 | 0.010 |
Why?
|
| Linoleic Acids | 1 | 1990 | 9 | 0.000 |
Why?
|
| Thyrotropin | 1 | 1990 | 35 | 0.000 |
Why?
|
| Linoleic Acid | 1 | 1990 | 19 | 0.000 |
Why?
|
| Viruses | 1 | 1991 | 81 | 0.000 |
Why?
|
| Thyroxine | 1 | 1990 | 55 | 0.000 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1990 | 95 | 0.000 |
Why?
|
| Lymphoma | 1 | 1990 | 101 | 0.000 |
Why?
|
| RNA | 1 | 1993 | 426 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1990 | 498 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1995 | 2067 | 0.000 |
Why?
|
| Gamma Rays | 1 | 1989 | 32 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 1991 | 222 | 0.000 |
Why?
|
| Biological Factors | 1 | 1989 | 19 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1990 | 199 | 0.000 |
Why?
|
| Radiation Tolerance | 1 | 1989 | 56 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1988 | 32 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1989 | 153 | 0.000 |
Why?
|
| Endothelium | 1 | 1987 | 21 | 0.000 |
Why?
|
| Macrophage Activation | 1 | 1987 | 115 | 0.000 |
Why?
|
| Inflammation | 1 | 1994 | 1194 | 0.000 |
Why?
|
| Glucose | 1 | 1990 | 478 | 0.000 |
Why?
|
| Culture Media | 1 | 1985 | 78 | 0.000 |
Why?
|
| DNA Replication | 1 | 1987 | 249 | 0.000 |
Why?
|
| Monocytes | 1 | 1987 | 361 | 0.000 |
Why?
|
| Rats, Brattleboro | 1 | 1985 | 2 | 0.000 |
Why?
|
| Lymphokines | 1 | 1985 | 67 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1985 | 61 | 0.000 |
Why?
|
| Brain | 1 | 1993 | 1611 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1985 | 256 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1985 | 137 | 0.000 |
Why?
|
| Hypophysectomy | 1 | 1983 | 2 | 0.000 |
Why?
|
| Methylglucosides | 1 | 1983 | 4 | 0.000 |
Why?
|
| Vagotomy | 1 | 1983 | 6 | 0.000 |
Why?
|
| 3-O-Methylglucose | 1 | 1983 | 16 | 0.000 |
Why?
|
| Niacinamide | 1 | 1983 | 33 | 0.000 |
Why?
|
| Pregnancy in Diabetics | 1 | 1983 | 12 | 0.000 |
Why?
|
| Intraoperative Care | 1 | 1983 | 38 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1983 | 287 | 0.000 |
Why?
|
| Anesthesia | 1 | 1983 | 52 | 0.000 |
Why?
|
| Emergencies | 1 | 1983 | 124 | 0.000 |
Why?
|
| Postoperative Care | 1 | 1983 | 125 | 0.000 |
Why?
|
| Risk | 1 | 1983 | 374 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1983 | 199 | 0.000 |
Why?
|